A woman who claimed in a lawsuit that GSK’s discontinued heartburn drug Zantac caused her breast cancer dropped her case ...
GSK and other drugmakers on Monday asked a Delaware court for permission to appeal a ruling allowing more than 70,000 ...
A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that ...
As the year rolls on, GSK continues to knock out personal injury lawsuits in the long-running legal saga over whether the ...
"The resulting influx of cases could have significant consequences for the efficient administration of justice in Delaware, ...
GSK said a plaintiff in an Illinois lawsuit against the company voluntarily dismissed her case, one of many legal disputes alleging its discontinued drug Zantac caused cancer. The British ...
Shore Capital analysts estimated that up to $30bn (£24bn) for litigation was already priced into GSK’s shares.
As Dame Emma Walmsley stood up to deliver GSK’s latest set of results last month, she was brimming with confidence. This was ...
Seamless reading experience. Save your favourite. Amgen is appealing a lower court's ruling that invalidated two of its patents on Repatha, a drug that can reduce risk of heart attack and stroke in ...
In its master circular on general insurance products, which takes immediate effect, Irdai specified, 'The customer may be required to submit only those documents directly related to claim settlement.
A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case ...
June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois ...